skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I'm trying to figure out why you were recommending Unity to your readers when it was most overvalued and now that it has fallen, you are less upbeat on the name. While hindsight is always 20-20, it seems to me that your views should have been reversed (discouraging readers from buying a stock that had popped up so much so quickly months ago but now perhaps being more interested in the name at this lower valuation). Do you feel that you were in error when you suggested this name as a pick? It was clearly too frothy over the last 6 months to one year when it was being recommended yet this did not factor into your comments it seems.
Read Answer Asked by Jason on March 15, 2022
Q: Hi 5i team.

Please give us your updated views on DKNG. In reviewing Q+A there has not been a thorough analysis of their technicals and fundamentals that I can see. Also, do you still like Flutter better as was stated in the past few questions?
What do they need to do to justify what appears to be still very lofty valuations even after steady declines this past year or so?
Is there an ETF that would make more sense to take out single co. risk?

Thanks for your guidance.
Read Answer Asked by Arthur on March 15, 2022
Q: Watching these two companies putting in new 52 week lows today. I know that the financial sector is out of favour but when I consider the growth rate of these two names I am wanting to purchase them. AFRM just stated it will exceed 3rd quarter and y/e outlooks. Could you give update and thoughts on these. Relative to growth are they expensive?
Read Answer Asked by Harry on March 15, 2022
Q: In your response to Marco's question on March 11 you mentioned you felt there were better opportunities in the US. Could you mention your top choices. Thank you.
Read Answer Asked by Michael on March 15, 2022
Q: At the current price of $187.67 FB, according to the company data section, is trading at 3.7 sales and analysts estimates show earnings $14.43 in 2023 for a forward PE of 13. Earnings growth is estimated to be 18.3% ($12.20 to $14.43). The analyst estimate stock target price $225 -450.
Question 1) Do you think the numbers in the company data are reasonable at this point?
Question 2) What would be the arguments against opening a position at this price if the hold was for 3-4 years

Thanks
Mike
Read Answer Asked by michael on March 14, 2022
Q: I have been watching UPST for quite a while, and I do own some (not a lot...yet). I notice that there has been consistent insider selling for quite a while, and can't help but wonder if this persistent selling (over months) is what is causing the stock to plummet. Does it suggest that there is a problem with the stock/company? I do understand there are many reasons for insiders to lighten up, even if the stock is solid, but the amount and persistence of the selling here does worry me. I'd like to get your impression of all the insider selling.
Read Answer Asked by arnold on March 14, 2022
Q: Looking for a few names in the US and Canada where you think recent market activity has left them with an attractive fundamental to Mr market delta. Thanks!
Read Answer Asked by Andrew on March 14, 2022
Q: Is there any particular news about why the Trade Desk (TTD) continues to decline? I thought the last quarter was quite strong. I also read there are rumors that Netlfix is considering ads which I would assume TTD would benefit greatly from. Can you comment on your thoughts moving forward.

Thanks for the fantastic service!
Read Answer Asked by Justin on March 14, 2022
Q: Hi Peter

I have question regarding the following list of “fallen angels”. These ten stocks have achieved significant drops in valuation since Dec. 31, 2020. Can you please rank these “fallen angels” in terms of the best risk-return profile over a five-to-ten-year hold? Everyone likes a bargain! Sometimes it is possible to survive a falling knife particularly if you use tungsten as a shield!

We cannot all be superman!

Baba
Fb
Jd
Lspd
Pypl
Roku
Shop
Sq
Weed
Zm


Thanks George
Read Answer Asked by George on March 14, 2022
Q: Could I have a proxy for APPS:US and GH:US? Would you buy back in 30 days or would you recommend another stock, if so, which ones? Same risk level and APPS/GH.

Thanks for your service?
Read Answer Asked by Ozzie on March 14, 2022
Q: I am looking to add a US blue-chip industrial company. How would you rank MMM, HON, ITW and ROP for management quality and overall business prospects? Given their current prices, how would you rank them for total return potential if purchased today for a long term hold?
Read Answer Asked by David on March 14, 2022
Q: You used to be quite positive on GILD in response to subscriber questions asking for recommendations in the US Healthcare sector. Have you given up on the GILD turnaround story? At what price would you buy in?

Now, your top choice seems to be ABBV on the basis that it is performing better and your belief that Humira patent issues are well-known and baked into the stock price. However, ABBV is trading at an all-time high (not just a 52 week high) and GILD is trading at a price that is a 52 week low and lower than its closing price in 2013. Which stock has the better risk-return profile and why? Even if you think ABBV is the better long term investment, I am still nervous buying in at all-time high prices - what would be a good entry point on a pull-back?
Read Answer Asked by David on March 14, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!